Troglitazone Patent Expiration
Troglitazone is Used for improving insulin sensitivity and managing Type II diabetes, including gestational diabetes. It was first introduced by Sankyo Usa Corp
Troglitazone Patents
Given below is the list of patents protecting Troglitazone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Prelay | US5859037 | Sulfonylurea-glitazone combinations for diabetes |
Nov 13, 2017
(Expired) | Sankyo |
| Prelay | US6011049 | Combinations for diabetes |
Nov 13, 2017
(Expired) | Sankyo |
| Rezulin | US5859037 | Sulfonylurea-glitazone combinations for diabetes |
Nov 13, 2017
(Expired) | Pfizer Pharms |
| Rezulin | US6011049 | Combinations for diabetes |
Nov 13, 2017
(Expired) | Pfizer Pharms |
| Prelay | US5602133 | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
Sep 15, 2013
(Expired) | Sankyo |
| Prelay | US6046202 | Use of thiazolidinedione derivatives in the treatment of insulin resistance |
Sep 15, 2013
(Expired) | Sankyo |
| Rezulin | US5602133 | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
Sep 15, 2013
(Expired) | Pfizer Pharms |
| Rezulin | US6046202 | Use of thiazolidinedione derivatives in the treatment of insulin resistance |
Sep 15, 2013
(Expired) | Pfizer Pharms |
Troglitazone's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List